Evidence map›Paper›PMID 36409059›Full record

ArticleeLife2022

SRSF6 balances mitochondrial-driven innate immune outcomes through alternative splicing of BAX.

Allison R Wagner, Chi G Weindel, Kelsi O West, Haley M Scott, Robert O Watson, Kristin L Patrick

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. AProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. An atlas of protein phosphorylation dynamics during interferon signaling.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Review
  10. Tumor-promoting effect and tumor immunity of SRSFs.Frontiers in cell and developmental biology · 2025
    Review
  11. Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Allison R WagnerDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.ORCID 0000-0002-6592-3741
Chi G WeindelDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.ORCID 0000-0002-8063-7794
Kelsi O WestDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.
Haley M ScottDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.
Robert O WatsonDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.ORCID 0000-0003-4976-0759
Kristin L PatrickDepartment of Microbial Pathogenesis and Immunology, Texas A&M Health, School of Medicine, Bryan, United States.ORCID 0000-0003-2442-4679
Texas A&M Health Science Center · US

Funding

Pre-mRNA splicing regulation is critical for controlling macrophage activationR35GM133720 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kristin Leigh Patrick · 2019 to 2026
$3.3M
Mitochondria as crucial regulators of innate immune outcomes during Mycobacterium tuberculosis infectionR01AI155621 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PATRICK, KRISTIN LEIGH, WATSON, ROBERT OWEN · 2021 to 2025
$2.9M
Determining the impact of post-translational modification on Serine Arginine Splicing Factor 7 during macrophage activationF31GM143893 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI SCOTT, HALEY MARIE · 2021 to 2023
$87k
NIAID NIH HHS R01 AI155621NIGMS NIH HHS F31 GM143893NIGMS NIH HHS R35 GM133720
6 · The paper itself

Abstract

To mount a protective response to infection while preventing hyperinflammation, gene expression in innate immune cells must be tightly regulated. Despite the importance of pre-mRNA splicing in shaping the proteome, its role in balancing immune outcomes remains understudied. Transcriptomic analysis of murine macrophage cell lines identified Serine/Arginine Rich Splicing factor 6 (SRSF6) as a gatekeeper of mitochondrial homeostasis. SRSF6-dependent orchestration of mitochondrial health is directed in large part by alternative splicing of the pro-apoptosis pore-forming protein BAX. Loss of SRSF6 promotes accumulation of BAX-κ, a variant that sensitizes macrophages to undergo cell death and triggers upregulation of interferon stimulated genes through cGAS sensing of cytosolic mitochondrial DNA. Upon pathogen sensing, macrophages regulate SRSF6 expression to control the liberation of immunogenic mtDNA and adjust the threshold for entry into programmed cell death. This work defines BAX alternative splicing by SRSF6 as a critical node not only in mitochondrial homeostasis but also in the macrophage's response to pathogens.

Indexed as

Alternative Splicingbcl-2-Associated X ProteinImmunity, InnateMitochondriaAnimalsDNA, MitochondrialMicePhosphoproteinsSerine-Arginine Splicing FactorsBax protein, mousebcl-2-Associated X ProteinDNA, MitochondrialPhosphoproteinsSerine-Arginine Splicing FactorsSRSF6 protein, mouseapoptosiscgas/stingchromosomesgene expressionimmunologyinflammationmitochondrial DNAmouseMycobacterium tuberculosispre-mRNA splicingserine-arginine rich

Identifiers

PMID36409059
PMCPMC9718523
OpenAlexW4309511567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.